PSA

Prostate-Specific Antigen

Q: Does a high PSA mean I have prostate cancer?

No. Most men with an elevated PSA do not have prostate cancer. The most common cause of mildly elevated PSA is benign prostatic hyperplasia (BPH), which is nearly universal in older men. Only about 25% of men who undergo biopsy for an elevated PSA are diagnosed with cancer. PSA is a sensitive but not specific test—it detects prostate abnormalities, not specifically cancer. Additional tests (free PSA, MRI, biomarker panels) help refine which elevated PSAs warrant biopsy.

Q: Should I get a PSA test?

This is a personal decision that should be made with your doctor through shared decision-making. Current guidelines recommend discussing screening with men aged 55–69 and starting the conversation earlier (age 40–45) for high-risk groups (African American men, those with a first-degree relative diagnosed with prostate cancer before age 65). The benefits of screening include earlier detection of aggressive cancers; the risks include false positives, anxiety, unnecessary biopsies, and potential overtreatment of indolent cancers. Your individual risk factors, values, and preferences should guide the decision.

Q: How do I prepare for a PSA test?

Avoid ejaculation for 48 hours before the test, as it can transiently raise PSA. Avoid vigorous cycling or activities that put pressure on the perineum for 48 hours. If you have a urinary tract infection or prostatitis, postpone the test until treatment is complete. Inform your doctor if you take finasteride or dutasteride, as these drugs reduce PSA by approximately 50% and the result must be adjusted. The blood draw itself requires no fasting.

Outros

Última revisão: 7 de abril de 2026. Abordagem de fontes: contexto padrão de interpretação laboratorial, material médico de referência e orientações clínicas ou de saúde pública quando relevantes.

O que é Prostate-Specific Antigen?

Prostate-specific antigen (PSA) is a serine protease glycoprotein produced almost exclusively by the epithelial cells of the prostate gland. Its physiological function is to liquefy the seminal coagulum after ejaculation, facilitating sperm motility. PSA circulates in the blood in two main forms: complexed PSA (bound to alpha-1-antichymotrypsin and other protease inhibitors, comprising 70–90% of total PSA) and free PSA (unbound, comprising 10–30% of total PSA). Total PSA measures both forms combined. Small amounts of PSA normally leak into the bloodstream, and the level reflects prostate size, integrity, and pathology.

PSA is the most widely used biomarker for prostate cancer screening and monitoring, though it is organ-specific rather than cancer-specific—any condition affecting the prostate can elevate PSA. Since its introduction in the late 1980s, PSA screening has been one of the most debated topics in medicine. While PSA screening can detect prostate cancer early, many detected cancers are indolent and would never cause harm, leading to potential overdiagnosis and overtreatment with significant side effects (incontinence, erectile dysfunction). Current guidelines from the AUA and USPSTF recommend shared decision-making for PSA screening in men aged 55–69, weighing individual risk factors and values.

Por que isso importa

PSA remains the cornerstone of prostate cancer detection and monitoring despite its limitations. An elevated PSA can lead to biopsy and early detection of aggressive prostate cancer, which is curable when caught early—the 5-year survival rate for localized prostate cancer exceeds 99%. PSA is also essential for monitoring men with known prostate cancer: after radical prostatectomy, any detectable PSA suggests recurrence; after radiation therapy, a rising PSA (biochemical recurrence) triggers further evaluation. PSA kinetics—including PSA velocity (rate of change over time) and PSA doubling time—provide additional prognostic information. Free PSA percentage helps distinguish cancer from benign conditions: a lower free PSA percentage (<10%) increases cancer suspicion, while a higher percentage (>25%) suggests benign disease.

Faixas de referência normais

Grupo	Faixa	Unidade
Men 40–49 years	0–2.5	ng/mL
Men 50–59 years	0–3.5	ng/mL
Men 60–69 years	0–4.5	ng/mL
Men 70–79 years	0–6.5	ng/mL
General screening threshold	<4.0	ng/mL

As faixas de referência podem variar entre laboratórios. Sempre compare seus resultados com as faixas fornecidas pelo seu local de exame.

O que significam níveis altos de PSA

Causas comuns

Prostate cancer
Benign prostatic hyperplasia (BPH)—the most common cause of mild PSA elevation
Prostatitis (bacterial or non-bacterial)
Urinary tract infection
Recent ejaculation (can raise PSA for 24–48 hours)
Vigorous exercise, particularly cycling
Recent prostate biopsy or cystoscopy
Urinary retention
Increasing age and prostate size

Possíveis sintomas

PSA elevation itself is asymptomatic—it is detected through blood testing
Prostate cancer: often asymptomatic early; advanced disease may cause urinary difficulty, bone pain, weight loss
BPH: urinary frequency, urgency, weak stream, nocturia, incomplete emptying
Prostatitis: pelvic pain, painful urination, fever (if bacterial)

O que fazer: An elevated PSA warrants careful evaluation. Your doctor will consider your age, race, family history, PSA trend over time, and digital rectal exam findings. Additional tests may include free PSA percentage (low free PSA increases cancer suspicion), PSA density (PSA divided by prostate volume), 4Kscore or PHI (Prostate Health Index), and prostate MRI. If cancer risk is sufficiently elevated, a prostate biopsy (ideally MRI-guided) is performed. Not all elevated PSAs require biopsy—active surveillance with repeat PSA testing is appropriate in many cases.

O que significam níveis baixos de PSA

Causas comuns

5-alpha reductase inhibitors (finasteride, dutasteride) reduce PSA by approximately 50%
Obesity (dilutional effect from larger blood volume)
Certain herbal supplements
After radical prostatectomy (PSA should be undetectable)

Possíveis sintomas

Low PSA does not cause symptoms
Low PSA is generally reassuring regarding prostate cancer risk

O que fazer: If taking finasteride or dutasteride, the PSA result should be doubled for accurate interpretation. Very low PSA in a man not on these medications is reassuring. After radical prostatectomy, PSA should be undetectable (<0.1 ng/mL); any rise above this threshold suggests biochemical recurrence. No intervention is needed for naturally low PSA levels.

Quando o exame de PSA é recomendado?

As part of shared decision-making for prostate cancer screening in men aged 55–69
Earlier screening (age 40–54) for high-risk men (African American, family history of prostate cancer)
When prostate symptoms are present (urinary difficulties, pelvic pain)
For monitoring after prostate cancer treatment (surgery, radiation, hormonal therapy)
When evaluating suspected prostatitis

Perguntas frequentes

No. Most men with an elevated PSA do not have prostate cancer. The most common cause of mildly elevated PSA is benign prostatic hyperplasia (BPH), which is nearly universal in older men. Only about 25% of men who undergo biopsy for an elevated PSA are diagnosed with cancer. PSA is a sensitive but not specific test—it detects prostate abnormalities, not specifically cancer. Additional tests (free PSA, MRI, biomarker panels) help refine which elevated PSAs warrant biopsy.

This is a personal decision that should be made with your doctor through shared decision-making. Current guidelines recommend discussing screening with men aged 55–69 and starting the conversation earlier (age 40–45) for high-risk groups (African American men, those with a first-degree relative diagnosed with prostate cancer before age 65). The benefits of screening include earlier detection of aggressive cancers; the risks include false positives, anxiety, unnecessary biopsies, and potential overtreatment of indolent cancers. Your individual risk factors, values, and preferences should guide the decision.

Avoid ejaculation for 48 hours before the test, as it can transiently raise PSA. Avoid vigorous cycling or activities that put pressure on the perineum for 48 hours. If you have a urinary tract infection or prostatitis, postpone the test until treatment is complete. Inform your doctor if you take finasteride or dutasteride, as these drugs reduce PSA by approximately 50% and the result must be adjusted. The blood draw itself requires no fasting.

Biomarcadores relacionados

TTestosterona CrCreatinina

Referências e abordagem de revisão

As páginas do glossário de biomarcadores são explicações educativas e devem ser interpretadas junto com as faixas de referência e observações fornecidas pelo seu laboratório e pelo seu médico. Para conhecer nossos padrões editoriais e processo de revisão, veja nossa Política editorial e a nossa revisão de conteúdo.

Quer analisar seus níveis de PSA?

Envie seus resultados de exames para receber uma análise instantânea com IA de todos os seus biomarcadores.

Enviar resultados de exames →

Aviso médico: Estas informações são apenas educativas e não substituem orientação, diagnóstico ou tratamento médico profissional. As faixas de referência podem variar entre laboratórios. Sempre converse com seu profissional de saúde sobre a interpretação dos seus resultados específicos.